Genome & Co. engages in research and development of dietary supplements, cosmeceuticals, and new drugs utilizing human microbiome. The company was founded by Ji-Soo Bae and Han-Su Park on September 24, 2015 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company